Trials / Completed
CompletedNCT01070810
Thiamine as a Metabolic Resuscitator in Septic Shock
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The major goal of this project is to determine whether the use of thiamine in patients with septic shock will result in attenuation of lactic acidosis and a more rapid reversal of shock.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D5W | Dextrose 5% |
| DRUG | Thiamine | Thiamine 200mg in 50ml D5W |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2010-02-18
- Last updated
- 2017-05-15
- Results posted
- 2017-05-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01070810. Inclusion in this directory is not an endorsement.